These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9131951)

  • 1. The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs.
    García Rodríguez LA; Wallander MA; Stricker BH
    Br J Clin Pharmacol; 1997 Feb; 43(2):183-8. PubMed ID: 9131951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs.
    García Rodríguez LA; Jick H
    BMJ; 1994 Feb; 308(6927):503-6. PubMed ID: 8136667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom.
    García Rodríguez LA; Ruigómez A; Jick H
    Pharmacotherapy; 1997; 17(4):721-8. PubMed ID: 9250549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of acute pancreatitis associated with acid-suppressing drugs.
    Eland IA; Alvarez CH; Stricker BH; Rodríguez LA
    Br J Clin Pharmacol; 2000 May; 49(5):473-8. PubMed ID: 10792205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prevention of upper gastrointestinal bleeding associated with maintenance acid-suppressing treatment in patients with peptic ulcer bleed.
    García Rodríguez LA; Ruigómez A
    Epidemiology; 1999 May; 10(3):228-32. PubMed ID: 10230829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes.
    Ruigómez A; García Rodríguez LA; Cattaruzzi C; Troncon MG; Agostinis L; Wallander MA; Johansson S
    Am J Epidemiol; 1999 Sep; 150(5):476-81. PubMed ID: 10472947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic effects of drugs used in the treatment of peptic ulcer disease.
    Lewis JH
    Am J Gastroenterol; 1987 Oct; 82(10):987-1003. PubMed ID: 2889354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole, other antiulcer drugs and newly diagnosed gout.
    Meier CR; Jick H
    Br J Clin Pharmacol; 1997 Aug; 44(2):175-8. PubMed ID: 9278205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole, H2 blockers, and polyarthralgia: case-control study.
    Meier CR; Jick H
    BMJ; 1997 Nov; 315(7118):1283. PubMed ID: 9390057
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal disease and acid-suppressing drugs.
    García Rodríguez LA; Wallander MA; Johanson S; Björck S
    Pharmacoepidemiol Drug Saf; 1997 Jul; 6(4):247-51. PubMed ID: 15073775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of the anti-ulcer medications ranitidine, cimetidine, and omeprazole following administration of multiple doses to exercised Thoroughbred horses.
    Knych HK; Stanley SD; Arthur RM; McKemie DS
    J Vet Pharmacol Ther; 2017 Jan; 40(1):92-96. PubMed ID: 27292271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis following treatments with famotidine and then cimetidine.
    Hashimoto F; Davis RL; Egli D
    Ann Pharmacother; 1994 Jan; 28(1):37-9. PubMed ID: 8123956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ranitidine and cimetidine in the treatment of chronic gastric ulcer. A double-blind trial.
    Kellow JE; Barr GD; Cowen AE; Ward M; Wood L; Piper DW
    Digestion; 1983; 27(2):105-10. PubMed ID: 6313458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users.
    Møller H; Nissen A; Mosbech J
    Gut; 1992 Sep; 33(9):1166-9. PubMed ID: 1358764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of cimetidine and ranitidine on drug metabolism of the liver].
    Homann J; Paul F; Kratz F; Leimenstoll G; Kamenisch W; Matthes KJ
    Med Welt; 1983 Mar; 34(10):313-5. PubMed ID: 6302436
    [No Abstract]   [Full Text] [Related]  

  • 16. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists.
    Ahmadi A; Ebrahimzadeh MA; Ahmad-Ashrafi S; Karami M; Mahdavi MR; Saravi SS
    Fundam Clin Pharmacol; 2011 Feb; 25(1):72-9. PubMed ID: 20070855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs.
    Pérez Gutthann S; García Rodríguez LA
    Epidemiology; 1993 Nov; 4(6):496-501. PubMed ID: 8268277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T; Lemaire M; Agostini H
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
    Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.